Yan Fa Xu
Corporate Officer/Principal chez Tianjin Wanjia Pharmacy Co. Ltd.
Postes actifs de Yan Fa Xu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Tianjin Wanjia Pharmacy Co. Ltd. | Corporate Officer/Principal | 01/09/2005 | - |
Historique de carrière de Yan Fa Xu
Anciens postes connus de Yan Fa Xu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GOLDSTONE CAPITAL GROUP LIMITED | Director/Board Member | 16/06/2017 | 02/07/2021 |
| Chairman | 02/07/2021 | 11/10/2022 | |
| Independent Dir/Board Member | 16/06/2017 | 02/07/2021 | |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Sales & Marketing | 01/02/2001 | 01/09/2005 |
| Beijing Tri-Prime Gene Pharmaceutical Co. Ltd. | Sales & Marketing | 01/02/2001 | 01/09/2005 |
| Beijing Xiehe Pharmaceutical Co. Ltd. | Sales & Marketing | 01/04/1999 | 01/02/2001 |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Corporate Officer/Principal | 01/10/1997 | 01/03/1999 |
Statistiques
Internationale
| Chine | 6 |
| Hong Kong | 2 |
Opérationnelle
| Sales & Marketing | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
 | Health Technology |
| Entreprise privées | 4 |
|---|---|
Goldstone Capital Group Ltd.
 Goldstone Capital Group Ltd. Investment ManagersFinance Goldstone Capital Group Ltd. operates as an investment holding company, which invests in a diversified portfolio of investments in listed and unlisted enterprises in Hong Kong and the PRC. It also engages in transactions in options and futures which are traded on recognized securities exchanges, futures exchanges and other over-the-counter markets. The company was founded on April 15, 2003 and is headquartered in Hong Kong. | Finance |
| Tianjin Wanjia Pharmacy Co. Ltd. | |
| Beijing Xiehe Pharmaceutical Co. Ltd. | |
| Beijing Tri-Prime Gene Pharmaceutical Co. Ltd. |
